EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

scCT-DB, an omnibus for cancer patient-derived paired pre- and post-treatment single-cell transcriptomes to reveal drug perturbation and drug resistance mechanisms

Shurui Ma, Jianzhou Jiang iD, Ruiyu Zhang, Xinyi Ren, Dan Li, Xiangdong Li, Hong Mu, Peng Liu, Li Zuo, Tingting Zhao, Anxin Gu, Dong Li iD und 1 weitere

Nucleic Acids Research · 06.01.2026 · 54 (D1) · D1616-D1633

DOI: 10.1093/nar/gkaf1065 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Nucleic Acids Research, online erschienen am 29.10.2025. Verfasst von Shurui Ma und 12 weiteren Autor:innen. Beteiligte Einrichtung: School of Basic Medical Sciences, Anhui Medical University, Hefei 230032, China. Hauptthemen laut MEDLINE: Single-Cell Analysis, Drug Resistance, Neoplasm, Neoplasms, Transcriptome. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: National Natural Science Foundation of China, National Key Research and Development Program of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Drug resistance continues to be a major challenge in cancer treatment. Understanding cellular and molecular dynamics after treatment is crucial for elucidating resistance mechanisms. Single-cell RNA sequencing (scRNA-seq) of paired pre- and post-treatment patient samples enables high-resolution exploration of such dynamics, but rapidly accumulated relevant data bring challenges for easy data access, integration, and reuse. Therefore, we present the Cancer Treatment-related Single-Cell transcriptome DataBase (scCT-DB, http://scctdb.ncpsb.org.cn). scCT-DB has comprehensively collected 266 patient-derived paired pre- and post-treatment scRNA-seq datasets processed by a uniform pipeline and with detailed and structured metadata, most of which simultaneously include information on primary/acquired drug response. scCT-DB includes 6.19 million cells from 1142 original patient samples, 27 major cancer types, 96 therapeutic regimens, and 102 drugs (involving chemotherapy, immunotherapy, hormone therapy, and targeted therapy). scCT-DB also provides 48 dataset pairs with opposite primary response groupings and 41 longitudinal datasets with ≥3 sampling timepoints. Besides data browsing, download, and search, scCT-DB also supports single-dataset analysis (including cell abundance, gene, cell state, and intercellular communication perturbation analyses), dataset comparative and re-combination analyses, providing insights into drug perturbation mechanisms and their heterogeneity in patients, drug resistance mechanisms, and discovery of biomarkers predictive of treatment response, etc.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Single-Cell AnalysisDrug Resistance, NeoplasmNeoplasmsTranscriptomeDatabases, GeneticHumansGene Expression ProfilingAntineoplastic AgentsSequence Analysis, RNAGene Expression Regulation, Neoplastic

Substanzen

Antineoplastic Agents

Autor:innen und Institutionen

  • School of Basic Medical Sciences, Anhui Medical University, Hefei 230032, China.
  • State Key Laboratory of Medical Proteomics, National Center for Protein Sciences (Beijing), Academy of Military Medical Sciences, Beijing 102206, China.
  • School of Life Sciences, Hebei University, Baoding 071002, China.
  • Department of Radiation Oncology, Harbin Medical University Cancer Hospital, Harbin 150040, China.
  • Department of Emergency, Beijing Tiantan Hospital, Capital Medical University, Beijing 100070, China.

ORCID-Profile: Jianzhou Jiang, Dong Li, Zhongyang Liu

Förderung

  • National Natural Science Foundation of China
  • National Key Research and Development Program of China

Zitieren

APA

Ma, S., Jiang, J., Zhang, R., Ren, X., Li, D., Li, X., Mu, H., Liu, P., Zuo, L., Zhao, T., Gu, A., Li, D., & Liu, Z. (2026). scCT-DB, an omnibus for cancer patient-derived paired pre- and post-treatment single-cell transcriptomes to reveal drug perturbation and drug resistance mechanisms. Nucleic Acids Research, 54(D1), D1616-D1633. https://doi.org/10.1093/nar/gkaf1065

Vancouver

Ma S, Jiang J, Zhang R, Ren X, Li D, Li X, et al. scCT-DB, an omnibus for cancer patient-derived paired pre- and post-treatment single-cell transcriptomes to reveal drug perturbation and drug resistance mechanisms. Nucleic Acids Research. 2026;54(D1):D1616-D1633. doi:10.1093/nar/gkaf1065

BibTeX
@article{Ma2026,
  author = {Ma, Shurui and Jiang, Jianzhou and Zhang, Ruiyu and Ren, Xinyi and Li, Dan and Li, Xiangdong and Mu, Hong and Liu, Peng and Zuo, Li and Zhao, Tingting and Gu, Anxin and Li, Dong and Liu, Zhongyang},
  title = {scCT-DB, an omnibus for cancer patient-derived paired pre- and post-treatment single-cell transcriptomes to reveal drug perturbation and drug resistance mechanisms},
  journal = {Nucleic Acids Research},
  year = {2026},
  volume = {54},
  number = {D1},
  pages = {D1616--D1633},
  doi = {10.1093/nar/gkaf1065}
}
Kostenlos starten →